Literature DB >> 11955726

Is uniform target dose possible in IMRT plans in the head and neck?

K A Vineberg1, A Eisbruch, M M Coselmon, D L McShan, M L Kessler, B A Fraass.   

Abstract

PURPOSE: Various published reports involving intensity-modulated radiotherapy (IMRT) plans developed using automated optimization (inverse planning) have demonstrated highly conformal plans. These reported conformal IMRT plans involve significant target dose inhomogeneity, including both overdosage and underdosage within the target volume. In this study, we demonstrate the development of optimized beamlet IMRT plans that satisfy rigorous dose homogeneity requirements for all target volumes (e.g., +/-5%), while also sparing the parotids and other normal structures. METHODS AND MATERIALS: The treatment plans of 15 patients with oropharyngeal cancer who were previously treated with forward-planned multisegmental IMRT were planned again using an automated optimization system developed in-house. The optimization system allows for variable sized beamlets computed using a three-dimensional convolution/superposition dose calculation and flexible cost functions derived from combinations of clinically relevant factors (costlets) that can include dose, dose-volume, and biologic model-based costlets. The current study compared optimized IMRT plans designed to treat the various planning target volumes to doses of 66, 60, and 54 Gy with varying target dose homogeneity while using a flexible optimization cost function to minimize the dose to the parotids, spinal cord, oral cavity, brainstem, submandibular nodes, and other structures.
RESULTS: In all cases, target dose uniformity was achieved through steeply varying dose-based costs. Differences in clinical plan evaluation metrics were evaluated for individual cases (eight different target homogeneity costlets), and for the entire cohort of plans. Highly conformal plans were achieved, with significant sparing of both the contralateral and ipsilateral parotid glands. As the homogeneity of the target dose distributions was allowed to decrease, increased sparing of the parotids (and other normal tissues) may be achieved. However, it was shown that relatively few patients would benefit from the use of increased target inhomogeneity, because the range of improvement in the parotid dose is relatively limited. Hot spots in the target volumes are shown to be unnecessary and do not assist in normal tissue sparing.
CONCLUSION: Sparing of both parotids in patients receiving bilateral neck radiation can be achieved without compromising strict target dose homogeneity criteria. The geometry of the normal tissue and target anatomy are shown to be the major factor necessary to predict the parotid sparing that will be possible for any particular case.

Entities:  

Mesh:

Year:  2002        PMID: 11955726     DOI: 10.1016/s0360-3016(01)02800-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.

Authors:  Yun Li; Jeremy M G Taylor; Randall K Ten Haken; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-04       Impact factor: 7.038

Review 2.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

3.  Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.

Authors:  J-Y Lu; L-L Wu; J-Y Zhang; J Zheng; M L-M Cheung; C-C Ma; L-X Xie; B-T Huang
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

Review 4.  Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature.

Authors:  S W Loo; W M C Martin; P Smith; S Cherian; T W Roques
Journal:  Br J Radiol       Date:  2012-08       Impact factor: 3.039

5.  Incorporating single-side sparing in models for predicting parotid dose sparing in head and neck IMRT.

Authors:  Lulin Yuan; Q Jackie Wu; Fang-Fang Yin; Yuliang Jiang; David Yoo; Yaorong Ge
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

6.  Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

Authors:  Tim Dijkema; Cornelis P J Raaijmakers; Randall K Ten Haken; Judith M Roesink; Pètra M Braam; Anette C Houweling; Marinus A Moerland; Avraham Eisbruch; Chris H J Terhaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-07       Impact factor: 7.038

7.  Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.

Authors:  Francis P Worden; Bhavna Kumar; Julia S Lee; Gregory T Wolf; Kitrina G Cordell; Jeremy M G Taylor; Susan G Urba; Avraham Eisbruch; Theodoros N Teknos; Douglas B Chepeha; Mark E Prince; Christina I Tsien; Nisha J D'Silva; Kun Yang; David M Kurnit; Heidi L Mason; Tamara H Miller; Nancy E Wallace; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

8.  Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy.

Authors:  Carol-Anne Murdoch-Kinch; Hyugnjin M Kim; Karen A Vineberg; Jonathan A Ship; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-11       Impact factor: 7.038

9.  The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets.

Authors:  Aron Popovtzer; Iris Gluck; Douglas B Chepeha; Theodoros N Teknos; Jeffrey S Moyer; Mark E Prince; Carol R Bradford; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-08       Impact factor: 7.038

10.  A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapy.

Authors:  Malcolm D Mattes; Jennifer C Lee; Sara Elnaiem; Adel Guirguis; N C Ikoro; Hani Ashamalla
Journal:  Radiat Oncol J       Date:  2014-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.